The interpretation on guidelines for diagnosis and treatment of chronic gastritis in China (2022, Shanghai): chemoprevention of cancerization in chronic atrophic gastritis
10.3760/cma.j.cn311367-20230618-00282
- VernacularTitle:《中国慢性胃炎诊治指南(2022年，上海)》解读：慢性萎缩性胃炎癌变的化学预防
- Author:
Jingyuan FANG
1
Author Information
1. 上海交通大学医学院附属仁济医院消化内科 上海市消化疾病研究所，上海 200001
- Keywords:
Chronic gastritis;
Gastritis, atrophic;
Carcinomatous change;
Chemoprevention;
Guideline interpretation
- From:
Chinese Journal of Digestion
2023;43(8):513-515
- CountryChina
- Language:Chinese
-
Abstract:
Chronic atrophic gastritis is a common gastrointestinal disease in our country. Clinicians and patients attach great importance to the treatment and prevention of atrophic gastritis. The guidelines for diagnosis and treatment of chronic gastritis in China (2022, Shanghai) was released in March 2023. Based on content of the guidelines on the treatment and prevention of cancerization in atrophic gastritis, this article interprets the chemoprevention of cancerization in chronic atrophic gastritis.
